Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q69555276
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010735.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q69555276
|
024
|
|
|
‡a
0000-0002-8688-8244
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q69555276
|
100
|
0 |
|
‡a
M P Martinez-Montiel
‡9
ast
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
Maria Del Pilar Martinez Montiel
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
M P Martinez-Montiel
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's Biologic therapies for chronic inflammatory bowel disease.
|
670
|
|
|
‡a
Author's Budd-Chiari syndrome associated with nodular regenerative hyperplasia of the liver
|
670
|
|
|
‡a
Author's Current stage in inflammatory bowel disease: What is next?
|
670
|
|
|
‡a
Author's Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
|
670
|
|
|
‡a
Author's Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
|
670
|
|
|
‡a
Author's Multiple gastric carcinoids, atrophic gastritis, hypergastrinemia: a confirmed association (a new case)
|
670
|
|
|
‡a
Author's Pharmacologic therapy for inflammatory bowel disease refractory to steroids
|
670
|
|
|
‡a
Author's Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?
|
670
|
|
|
‡a
Author's [Systemic manifestations in primary biliary cirrhosis]
|
670
|
|
|
‡a
Author's Therapy with stem cells in inflammatory bowel disease
|
670
|
|
|
‡a
Author's Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient
|
909
|
|
|
‡a
(orcid) 0000000286888244
‡9
1
|
919
|
|
|
‡a
ustekinumabiseffectiveandsafeinthetreatmentofcrohnsdiseaserefractorytoantitnfαinanorthotopiclivertransplantpatient
‡A
Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient
‡9
1
|
919
|
|
|
‡a
therapywithstemcellsininflammatoryboweldisease
‡A
Therapy with stem cells in inflammatory bowel disease
‡9
1
|
919
|
|
|
‡a
systemicmanifestationsinprimarybiliarycirrhosis
‡A
[Systemic manifestations in primary biliary cirrhosis]
‡9
1
|
919
|
|
|
‡a
stemcelltherapyininflammatoryboweldiseaseapromisingtherapeuticstrategy
‡A
Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?
‡9
1
|
919
|
|
|
‡a
pharmacologictherapyforinflammatoryboweldiseaserefractorytosteroids
‡A
Pharmacologic therapy for inflammatory bowel disease refractory to steroids
‡9
1
|
919
|
|
|
‡a
multiplegastriccarcinoidsatrophicgastritishypergastrinemiaaconfirmedassociationanewcase
‡A
Multiple gastric carcinoids, atrophic gastritis, hypergastrinemia: a confirmed association (a new case)
‡9
1
|
919
|
|
|
‡a
infliximabdoseescalationasaneffectivestrategyformanagingsecondarylossofresponseinulcerativecolitis
‡A
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
‡9
1
|
919
|
|
|
‡a
evolutionafterantitnfdiscontinuationinpatientswithinflammatoryboweldiseaseamulticenterlongtermfollowupstudy
‡A
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
‡9
1
|
919
|
|
|
‡a
currentstageininflammatoryboweldiseasewhatisnext
‡A
Current stage in inflammatory bowel disease: What is next?
‡9
1
|
919
|
|
|
‡a
buddchiarisyndromeassociatedwithnodularregenerativehyperplasiaoftheliver
‡A
Budd-Chiari syndrome associated with nodular regenerative hyperplasia of the liver
‡9
1
|
919
|
|
|
‡a
biologictherapiesforchronicinflammatoryboweldisease
‡A
Biologic therapies for chronic inflammatory bowel disease.
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
DNB|1064779018
|
996
|
|
|
‡2
BNE|XX4955902
|
996
|
|
|
‡2
J9U|987007370926505171
|
996
|
|
|
‡2
SZ|1064779018
|
996
|
|
|
‡2
ISNI|0000000107851340
|
996
|
|
|
‡2
DNB|1237141907
|
996
|
|
|
‡2
LC|ns2015000655
|
996
|
|
|
‡2
BNE|XX1412497
|
996
|
|
|
‡2
LC|n 2007024128
|
996
|
|
|
‡2
LC|ns2012005314
|
996
|
|
|
‡2
LC|no2008075523
|
996
|
|
|
‡2
LC|n 99269743
|
996
|
|
|
‡2
BNC|981058530090906706
|
996
|
|
|
‡2
ISNI|000000038761017X
|
996
|
|
|
‡2
LC|n 2004140318
|
996
|
|
|
‡2
DNB|1310465142
|
996
|
|
|
‡2
LC|n 2012024456
|
996
|
|
|
‡2
BNF|17811405
|
996
|
|
|
‡2
ISNI|0000000036436165
|
996
|
|
|
‡2
LC|nb2018000928
|
996
|
|
|
‡2
LC|ns2023001980
|
996
|
|
|
‡2
LC|no2018113228
|
996
|
|
|
‡2
LC|no2006101944
|
996
|
|
|
‡2
BNC|981058604970606706
|
996
|
|
|
‡2
ISNI|0000000043630804
|
996
|
|
|
‡2
BNE|XX935772
|
996
|
|
|
‡2
ISNI|0000000496823641
|
996
|
|
|
‡2
DNB|1056466243
|
996
|
|
|
‡2
J9U|987007334981505171
|
996
|
|
|
‡2
ISNI|0000000118308714
|
996
|
|
|
‡2
BNF|15791205
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|